Literature DB >> 15231857

Epidemiology and prevention of pancreatic cancer.

Albert B Lowenfels1, Patrick Maisonneuve.   

Abstract

Pancreatic cancer is an uncommon tumor, but because the mortality rate approaches 100%, this form of cancer has now become a common cause of cancer mortality. In the United States it is the fourth most frequent cause of cancer mortality; in Japan it ranks as the fifth commonest cause of death from cancer. Smoking is the major known risk factor for pancreatic cancer, accounting for approximately 25-30% of all cases. Some of the time-dependent changes in the frequency of pancreatic cancer can be explained by smoking trends. Aggressive public health measures to control smoking would substantially reduce the burden of pancreatic cancer. Dietary factors are less important for pancreatic cancer than for other digestive tract tumors, but consumption of a diet with adequate quantities of fruits and vegetables, plus control of calories either by dietary measures or by exercise will help to prevent this lethal tumor. There are more than a dozen inherited germline mutations that increase the risk of pancreatic cancer. Of these, hereditary pancreatitis confers the greatest risk, while BRCA2 mutations are the commonest inherited disorder. In addition to germline defects, there are several common polymorphisms in genes that control detoxification of environmental carcinogens that may alter the risk of pancreatic cancer. More research will be needed in this area, to explain and to clarify the interaction between genes and environmental factors.

Entities:  

Mesh:

Year:  2004        PMID: 15231857     DOI: 10.1093/jjco/hyh045

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  57 in total

1.  In vitro and in vivo anticancer activity of a novel nano-sized formulation based on self-assembling polymers against pancreatic cancer.

Authors:  Clare Hoskins; Mehdi Ouaissi; Sofia Costa Lima; Woei Ping Cheng; Inês Loureirio; Eric Mas; Dominique Lombardo; Anabela Cordeiro-da-Silva; Ali Ouaissi; Paul Kong Thoo Lin
Journal:  Pharm Res       Date:  2010-09-25       Impact factor: 4.200

2.  Pancreatic cancer patients who smoke and drink are diagnosed at younger ages.

Authors:  Randall E Brand; Julia B Greer; Eugene Zolotarevsky; Rhonda Brand; Hongyan Du; Diane Simeone; Anna Zisman; Addi Gorchow; Shih-Yuan Connie Lee; Hemant K Roy; Michelle A Anderson
Journal:  Clin Gastroenterol Hepatol       Date:  2009-06-26       Impact factor: 11.382

3.  Three cases of locally advanced pancreatic cancer successfully treated with chemoradiation and chemotherapy.

Authors:  Masashi Taguchi; Yoshikuni Nagashio; Yasuyuki Kihara; Masaaki Hiura; Shintaro Abe; Mitsuyoshi Yamamoto; Masaru Harada
Journal:  Clin J Gastroenterol       Date:  2010-06-05

4.  Pancreatic Cancer Incidence, Mortality, and Survival in Puerto Rico, 2001-2015.

Authors:  M Castañeda-Avila; C R Torres-Cintrón; A Cruz-Benítez; W Fuentes-Payán; A Maldonado-Albertorio; L Nieves-Ferrer; P Padró-Juarbe; R Soto-Abreu; N Perez-Ríos; K J Ortiz-Ortiz; P Magno; A P Ortiz
Journal:  P R Health Sci J       Date:  2019-09       Impact factor: 0.705

5.  Effects of CPG ODN on biological behavior of PANC-1 and expression of TLR9 in pancreatic cancer.

Authors:  Han-Qing Wu; Bo Wang; Shi-Kai Zhu; Yuan Tian; Jing-Hui Zhang; He-Shui Wu
Journal:  World J Gastroenterol       Date:  2011-02-28       Impact factor: 5.742

6.  Evaluation of innate and adaptive immunity contributing to the antitumor effects of PD1 blockade in an orthotopic murine model of pancreatic cancer.

Authors:  Marcela D'Alincourt Salazar; Edwin R Manuel; Weimin Tsai; Massimo D'Apuzzo; Leanne Goldstein; Bruce R Blazar; Don J Diamond
Journal:  Oncoimmunology       Date:  2016-03-16       Impact factor: 8.110

7.  Risk factors for pancreatic cancer: case-control study.

Authors:  Manal M Hassan; Melissa L Bondy; Robert A Wolff; James L Abbruzzese; Jean-Nicolas Vauthey; Peter W Pisters; Douglas B Evans; Rabia Khan; Ta-Hsu Chou; Renato Lenzi; Li Jiao; Donghui Li
Journal:  Am J Gastroenterol       Date:  2007-08-31       Impact factor: 10.864

8.  Aspirin inhibits proliferation of gemcitabine-resistant human pancreatic cancer cells and augments gemcitabine-induced cytotoxicity.

Authors:  Yan-qiu Ou; Wen bo Zhu; Yan Li; Peng-xin Qiu; Yi-jun Huang; Jun Xie; Song-min He; Xiao-ke Zheng; Tian-dong Leng; Dong Xu; Guang-mei Yan
Journal:  Acta Pharmacol Sin       Date:  2009-12-07       Impact factor: 6.150

Review 9.  Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection.

Authors:  Andrew E Becker; Yasmin G Hernandez; Harold Frucht; Aimee L Lucas
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

10.  Gli1 maintains cell survival by up-regulating IGFBP6 and Bcl-2 through promoter regions in parallel manner in pancreatic cancer cells.

Authors:  Xuan-Fu Xu; Chuan-Yong Guo; Jun Liu; Wen-Juan Yang; Yu-Jing Xia; Ling Xu; Yong-Chun Yu; Xing-Peng Wang
Journal:  J Carcinog       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.